National Systemic Anti-Cancer Therapy (SACT) consent forms – forms for gynaecological cancers published

The regimen-specific consent forms for gynaecological cancers have been published on the Cancer Research UK (CRUK) website.  There are 24 forms for this tumour group:
 

  • BEP (5 day)
  • Bevacizumab
  • Carboplatin
  • Carboplatin-Etoposide
  • Carboplatin-Paclitaxel
  • Cisplatin
  • Cisplatin + Radiotherapy
  • Cisplatin-Etoposide
  • Cisplatin-Fluorouracil
  • Cisplatin-Fluorouracil + Radiotherapy
  • Cisplatin-Paclitaxel
  • Cisplatin-Topotecan
  • Doxorubicin
  • Doxorubicin-Cisplatin
  • EP (Etoposide-Cisplatin)
  • Etoposide (oral)
  • Gemcitabine
  • Gemcitabine-Carboplatin
  • Gemcitabine-Cisplatin
  • Liposomal doxorubicin (Caelyx®)
  • Liposomal doxorubicin (Caelyx®) – Carboplatin
  • Olaparib
  • Paclitaxel (day 1, 8 & 15)
  • Topotecan (IV)

 
Please visit www.cruk.org/sact_consent to view and download the forms.  Other forms, national guidance on consent for SACT, and further information is also available via www.cruk.org/sact_consent.
 
The National Chemotherapy Board published guidance on consent for SACT in July 2016 and recommends use of the regimen-specific forms in the UK.  The forms have been produced with support from CRUK.
 
Please do not hesitate to contact Rena Chauhan (Oncology Pharmacist – CRUK information lead, Guy’s and St. Thomas’ NHS Foundation Trust) if you have any queries: [email protected].
 
Rena Chauhan
4 January 2017
 

Latest News

By BOPA on 27th October 2025

Celebrating Success in the BOPA Immunotherapy Group

The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…

Read article
By BOPA on 27th October 2025

Celebrating Black History Month – Celebrating Excellence with Gisela Abbam

In celebration of Black History Month, the Kingston University BAME staff network  is excited to invite you to an inspiring session with Gisela Abbam,  Chair of the General Pharmaceutical Council (GPhC). Gisela…

Read article
By BOPA Committee on 26th October 2025

Immunotherapy Study Day at Royal Marsden Hospital

The team at the Royal Marsden Hospital are organising an immunotherapy study day on the 3rd December, please see link below for more information. A User Guide to Cancer Immunotherapy…

Read article
By BOPA Committee on 26th October 2025

Collaboration on Reviewing Existing SACT Protocols

Dear BOPA Members, As you may be aware, the National SACT Protocol Project is due to commence shortly in collaboration with the UK SACT Board and the Pharmaceutical Press. The…

Read article